<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="19" ids="28790">Serotonin</z:chebi> (5-hydroxytryptamine)(1B/1D) <z:chebi fb="4" ids="48705">agonists</z:chebi> can vasoconstrict coronary and cerebral arteries </plain></SENT>
<SENT sid="1" pm="."><plain>Chest, jaw, and arm discomfort, so-called "triptan sensations," are often felt to be noncardiac </plain></SENT>
<SENT sid="2" pm="."><plain>In Part 1 of this review, the relationship of triptans, coronary artery narrowing, and spasm was discussed, along with a case of a 53-year-old woman without cardiac risk factors who developed polymorphic <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> and <z:mp ids='MP_0004120'>cardiac ischemia</z:mp> with acquired corrected QT (QTc) interval prolongation following oral <z:chebi fb="0" ids="10650">sumatriptan</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>In Part 2 of this review, <z:hpo ids='HP_0002315'>headache</z:hpo> medications, drug-drug interactions, QTc prolongation, and <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> are appraised and discussed </plain></SENT>
<SENT sid="4" pm="."><plain>Triptans, <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo>, and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> by prescribing information are summarized </plain></SENT>
<SENT sid="5" pm="."><plain>The reader is provided tables on QTc prolongation by medication </plain></SENT>
<SENT sid="6" pm="."><plain>The problem of QTc prolongation with a variety of <z:hpo ids='HP_0002315'>headache</z:hpo> medications at conventional doses, including triptans, <z:chebi fb="19" ids="28790">serotonin</z:chebi> reuptake inhibitors (selective <z:chebi fb="19" ids="28790">serotonin</z:chebi> reuptake inhibitors and <z:chebi fb="19" ids="28790">serotonin</z:chebi> <z:chebi fb="1" ids="18357,33569">norepinephrine</z:chebi> reuptake inhibitors), other antidepressants, <z:chebi fb="5" ids="37956">antihistamines</z:chebi>, and antinauseants should lead to proactively obtaining electrocardiograms and more vigilant surveillance of <z:hpo ids='HP_0002315'>headache</z:hpo> patients </plain></SENT>
<SENT sid="7" pm="."><plain>This may be the place to start in protecting patients from these cardiac adverse events </plain></SENT>
</text></document>